103 related articles for article (PubMed ID: 23016773)
1. Liquid-based cytology with HPV triage of low-grade cytological abnormalities versus conventional cytology in cervical cancer screening.
Fröberg M; Norman I; Johansson B; Hjerpe A; Weiderpass E; Andersson S
Curr Pharm Des; 2013; 19(8):1406-11. PubMed ID: 23016773
[TBL] [Abstract][Full Text] [Related]
2. Aptima HPV Assay versus Hybrid Capture
Cook DA; Smith LW; Law J; Mei W; van Niekerk DJ; Ceballos K; Gondara L; Franco EL; Coldman AJ; Ogilvie GS; Jang D; Chernesky M; Krajden M
J Clin Virol; 2017 Feb; 87():23-29. PubMed ID: 27988420
[TBL] [Abstract][Full Text] [Related]
3. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
4. Triage Value of Cervical Exfoliated Cell DNA Ploidy Analysis in Cervical High-Risk Human Papillomavirus-Positive Women.
Chu B; Dong J; Chen Y; Ru X; Zhang W; Chen Y; Zhang X; Cheng X
J Low Genit Tract Dis; 2023 Oct; 27(4):331-336. PubMed ID: 37589311
[TBL] [Abstract][Full Text] [Related]
5. HPV for cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV-based primary screening to liquid-based cytology for cervical cancer.
Ogilvie GS; Krajden M; van Niekerk D; Smith LW; Cook D; Ceballos K; Lee M; Gentile L; Gondara L; Elwood-Martin R; Peacock S; Stuart G; Franco EL; Coldman AJ
Int J Cancer; 2017 Jan; 140(2):440-448. PubMed ID: 27685757
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus testing in young women: clinical outcomes of human papillomavirus triage in a UK cervical screening program.
McKenna M; McMenamin MM
Cancer Cytopathol; 2014 Sep; 122(9):702-10. PubMed ID: 24888573
[TBL] [Abstract][Full Text] [Related]
7. MAVARIC - a comparison of automation-assisted and manual cervical screening: a randomised controlled trial.
Kitchener HC; Blanks R; Cubie H; Desai M; Dunn G; Legood R; Gray A; Sadique Z; Moss S;
Health Technol Assess; 2011 Jan; 15(3):iii-iv, ix-xi, 1-170. PubMed ID: 21266159
[TBL] [Abstract][Full Text] [Related]
8. Risk assessment and clinical impact of liquid-based cytology, oncogenic human papillomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening (the FASE study).
Monsonego J; Hudgens MG; Zerat L; Zerat JC; Syrjänen K; Smith JS
Gynecol Oncol; 2012 Apr; 125(1):175-80. PubMed ID: 22233689
[TBL] [Abstract][Full Text] [Related]
9. 14-type HPV mRNA test in triage of HPV DNA-positive postmenopausal women with normal cytology.
Asciutto KC; Borgfeldt C; Forslund O
BMC Cancer; 2020 Oct; 20(1):1025. PubMed ID: 33097006
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA detection in cervical exfoliated cells as a triage for human papillomavirus-positive women.
Tian Q; Li Y; Wang F; Li Y; Xu J; Shen Y; Ye F; Wang X; Cheng X; Chen Y; Wan X; Lu W; Xie X
J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25190727
[TBL] [Abstract][Full Text] [Related]
11. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
12. Methylated
Su Y; Tang Y; Zhang T; Xu Y; Zhang Y; Shen Y; Qin L; Zhang L; Cao L; Zhou Y; Liou Y; Zhang M
Future Oncol; 2022 Jul; 18(23):2583-2592. PubMed ID: 35758002
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study.
Monsonego J; Hudgens MG; Zerat L; Zerat JC; Syrjänen K; Halfon P; Ruiz F; Smith JS
Int J Cancer; 2011 Aug; 129(3):691-701. PubMed ID: 20941740
[TBL] [Abstract][Full Text] [Related]
14. HPV mRNA testing in triage of women with ASC-US cytology may reduce the time for CIN2+diagnosis compared with repeat cytology.
Sørbye SW; Fismen S; Gutteberg TJ; Mortensen ES; Skjeldestad FE
Curr Pharm Des; 2013; 19(8):1401-5. PubMed ID: 23016772
[TBL] [Abstract][Full Text] [Related]
15. Pooled analysis of the performance of liquid-based cytology in population-based cervical cancer screening studies in China.
Pan QJ; Hu SY; Zhang X; Ci PW; Zhang WH; Guo HQ; Cao J; Zhao FH; Lytwyn A; Qiao YL
Cancer Cytopathol; 2013 Sep; 121(9):473-82. PubMed ID: 23907807
[TBL] [Abstract][Full Text] [Related]
16. Is a liquid-based cytology more sensitive than a conventional Pap smear?
Sigurdsson K
Cytopathology; 2013 Aug; 24(4):254-63. PubMed ID: 23331613
[TBL] [Abstract][Full Text] [Related]
17. High-risk human papillomavirus detection in women with low-grade squamous intraepithelial lesions or higher-grade cytology using the Cervista HPV HR test.
Gold MA; Thomas MA; Huh WK; Sarto GE; Day SP
J Low Genit Tract Dis; 2013 Jan; 17(1):51-7. PubMed ID: 22885641
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Triage Strategies for HPV-Positive Women: Canadian Cervical Cancer Screening Trial Results.
Isidean SD; Mayrand MH; Ramanakumar AV; Rodrigues I; Ferenczy A; Ratnam S; Coutlée F; Franco EL;
Cancer Epidemiol Biomarkers Prev; 2017 Jun; 26(6):923-929. PubMed ID: 28096198
[No Abstract] [Full Text] [Related]
19. Cervical cancer screening in sub-Saharan Africa: a randomized trial of VIA versus cytology for triage of HPV-positive women.
Bigoni J; Gundar M; Tebeu PM; Bongoe A; Schäfer S; Fokom-Domgue J; Catarino R; Tincho EF; Bougel S; Vassilakos P; Petignat P
Int J Cancer; 2015 Jul; 137(1):127-34. PubMed ID: 25420434
[TBL] [Abstract][Full Text] [Related]
20. Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand.
Khunamornpong S; Settakorn J; Sukpan K; Suprasert P; Srisomboon J; Intaraphet S; Siriaunkgul S
PLoS One; 2016; 11(6):e0158184. PubMed ID: 27336913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
